Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,229,781
+$29,014 QoQ
Shares Held
7,847
-0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#570
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONTAG A & ASSOCIATES INC holds $100,006,894 across 14 Drug Manufacturers - General names. NVS ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
29,430 | $35,299,227 | |
| 2 | JNJ |
Johnson & Johnson
|
89,578 | $22,750,124 | |
| 3 | ABBV |
AbbVie Inc.
|
72,344 | $18,204,644 | |
| 4 | MRK |
Merck & Co., Inc.
|
136,408 | $17,528,428 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
37,785 | $2,177,171 | |
| 6 | NVS |
Novartis AG
This page
|
7,847 | $1,229,781 | |
| 7 | PFE |
Pfizer Inc
|
50,191 | $1,208,599 | |
| 8 | AMGN |
Amgen Inc
|
2,744 | $993,657 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,229,781 | 7,847 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,200,767 | 7,861 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $1,054,154 | 7,646 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $981,036 | 7,650 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $916,650 | 7,575 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $844,461 | 7,575 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $737,123 | 7,575 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $871,276 | 7,575 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $806,434 | 7,575 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $732,729 | 7,575 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $805,033 | 7,973 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $822,621 | 8,076 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $834,222 | 8,267 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $751,456 | 8,168 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $741,817 | 8,177 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $650,721 | 8,561 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $548,092 | 6,484 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $568,971 | 6,484 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $569,167 | 6,507 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $520,447 | 6,364 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $580,651 | 6,364 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $543,994 | 6,364 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $619,838 | 6,564 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $679,505 | 7,814 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $648,848 | 7,429 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $615,324 | 7,463 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||